@AB1001_disciple $4B additional cost for Bluerock suddenly? Pls share your data. BlueRock/Bayer were already running a sham-controlled, double-blind pivotal Phase 3 as of 2025.
Crazy story: A bank analyst published a report showing Kalshi users lose money even faster than sports gamblers, so Kalshi first tried to pressure the data provider to change their data and then accused them and the analyst of conspiring to extort them when that doesn’t work.
@every is hosting a really valuable webinar on how to use Claude Code rn. Investment research is going to be increasingly efficient (tracking down due diligence/scuttlebutt on potential or existing stock positions) as AI lowers the cost of an "analyst's" help.
@ScienceofPD@BlueRockTx Don't know if $CLPT shareholders are following this study, but @Bayer subsidiary @BlueRockTx is using Clearpoint for these trials which are expected to enroll Phase II participants within months.
#ClearPoint is proud to support stem cell therapy trials sponsored by @Bayer / @BlueRockTx. If you're interested in learning more about these potentially ground-breaking therapies, check out this webcast tomorrow, Nov. 30th. Sign up: https://t.co/bIvj2PwrvQ #CLPT#StemCell